Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab

Documenti analoghi

• Leichte COVID-19-Erkrankung bei einem Patienten mit Multipler Sklerose und schwerer Depletion von T-Lymphozyten-Subsets infolge von Alemtuzumab
  di: Guevara, Carlos, et al.
  Pubblicazione: (2020)
• Alemtuzumab: COVID-19 infection and severe depletion of T-lymphocyte: case report
  Pubblicazione: (2020)
• Alemtuzumab depletion failure can occur in multiple sclerosis
  di: Dubuisson, Nicolas, et al.
  Pubblicazione: (2018)
• Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.
  di: Craig, J C, et al.
  Pubblicazione: (1985)
• Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations
  di: Guevara, Carlos, et al.
  Pubblicazione: (2020)